AJM300, an a4-Integrin Antagonist, Effective as Induction Therapy in Ulcerative Colitis
Investigators examined the safety and efficacy of a small-molecule α4-integrin antagonist, called AJM300, for treating ulcerative colitis.
All articles by Jessica Nye, PhD
Gastroparesis Peroral Endoscopic Myotomy Effective Long Term for Refractory Gastroparesis
Researchers sought to evaluate the efficacy of gastroparesis peroral endoscopic myotomy (G-POEM) after 4 years of follow up.
Young Adult Women, People of Color With Chest Pain Wait Longer at the Emergency Department
A study was conducted to evaluate sex and racial differences related to emergency department examinations among young adults with chest pain.
Predicting Diverticulitis Risk With DICA Classification and CODA Score
A team of researchers sought to determine the predictive value of DICA classification and CODA score for clinical outcomes of diverticulosis.
High-Protein, Drained Yogurt Alters Microbiome in Women With Overweight, Obesity
A team of researchers examined the effects on the microbiome from daily long-term consumption of high-protein, drained yogurt in women with overweight and obesity.
Less Sleep, Later Sleep Onset Associate With Depression Among Adolescents
Participants in this study were evaluated for sleep features using a combined heart rate and movement sensor and a subset of participants underwent semi-structured interviews to assess demographics and psychosocial measures.
Safety, Efficacy of DAAs for Hepatitis C Virus Genotype 6 Infection in People With HIV
A team of researchers analyzed the virologic response of hepatitis C virus to direct-acting antivirals in patients with HIV.
Long-Term Colectomy Risk Among Patients With Acute Severe Ulcerative Colitis
A team of researchers assessed long-term risk and predictors for colectomy in patients with acute severe UC in clinical remission post-treatment.
Interview With ASA President: Updated CDC Clinical Practice Guidelines for Prescribing Opioids
David Dickerson, MD, chair of the ASA Committee on Pain Medicine, discusses suggested changes and recommendations to the proposed clinical practice guidelines for prescribing opioids that were recently issued by the CDC.
Oral Microbiome Therapy Sustains Clinical Cure for Recurrent C difficile
Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.
- Loading...
Loading...
Next post in DDW 2022
Loading... 
Loading...